サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1356675

血栓管理デバイス市場レポート：2030年までの動向、予測、競合分析

Clot Management Devices Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

血栓管理デバイス市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年09月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

血栓管理デバイスの動向と予測

世界の血栓管理デバイス市場は、2024年から2030年までのCAGRが5.2%で、2030年までに推定25億米ドルに達すると予想されています。この市場の主な促進要因は、心血管疾患の有病率の上昇と高齢化、低侵襲手術への志向の高まり、技術の継続的な進歩です。世界の血栓管理装置市場の将来は、診断センターと病院市場にビジネスチャンスがあり、有望視されています。

血栓管理装置市場の洞察

Lucintelの予測では、神経血管塞栓摘出装置は、主に脳血管で発生する塞栓症のような病状の治療に役立つため、予測期間中に最も高い成長が見込まれます。

この市場において、病院は、心臓血管治療のために病院内の専門部門、高度なラボ、手術室の採用が増加しているため、最大のセグメントであり続けると思われます。

アジア太平洋は、心血管疾患の有病率の増加と同地域のヘルスケアインフラの改善により、予測期間中に最も高い成長が見込まれています。

本レポートでは、以下の11の主要な質問に回答しています：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の血栓管理デバイス市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の血栓管理デバイス市場動向（2018-2023）と予測（2024-2030）
  • 製品別の世界の血栓管理デバイス市場
    • 神経血管塞栓摘出術装置
    • 塞栓摘出術用バルーンカテーテル
    • 経皮的血栓除去装置
    • カテーテル指向性血栓溶解療法（CDT）デバイス
    • 下大静脈フィルター（IVCF）
  • 経皮的血栓除去術デバイスのタイプ別の世界の血栓管理デバイス市場
    • 吸引血栓除去装置
    • 経皮的機械的血栓除去装置
  • 最終用途別の世界の血栓管理デバイス市場
    • 診断センター
    • 病院
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の血栓管理デバイス市場
  • 北米の血栓管理デバイス市場
  • 欧州の血栓管理デバイス市場
  • アジア太平洋の血栓管理デバイス市場
  • その他地域血栓管理デバイス市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 製品別の世界の血栓管理デバイス市場の成長機会
    • 経皮的血栓除去術デバイスのタイプ別の世界の血栓管理デバイス市場の成長機会
    • 最終用途別の世界の血栓管理デバイス市場の成長機会
    • 地域別の世界の血栓管理デバイス市場の成長機会
  • 世界の血栓管理デバイス市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の血栓管理デバイス市場の能力拡大
    • 世界の血栓管理デバイス市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Medtronic
  • Boston Scientific Corporation
  • iVascular SLU
  • Teleflex
  • Edwards Lifesciences Corporation
  • LeMaitre Vascular
  • Vascular Solutions
  • Straub Medical
  • Cook Medical
  • DePuy Synthes
目次

Clot Management Devices Trends and Forecast

The future of the global clot management devices market looks promising with opportunities in the diagnostic center and hospital markets. The global clot management devices market is expected to reach an estimated $2.5 billion by 2030 with a CAGR of 5.2% from 2024 to 2030. The major drivers for this market are rising prevalence of cardiovascular diseases and ageing population, increasing inclination towards minimally invasive surgeries and on-going advancements in technologies.

A more than 150-page report is developed to help in your business decisions.

Clot Management Devices by Segment

The study includes a forecast for the global clot management devices by product, percutaneous thrombectomy devices type, end use, and region.

Clot Management Devices Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Neurovascular Embolectomy Devices
  • Embolectomy Balloon Catheters
  • Percutaneous Thrombectomy Devices
  • Catheter-Directed Thrombolysis (CDT) Devices
  • Inferior Vena Cava Filters (IVCF)

Clot Management Devices Market by Percutaneous Thrombectomy Devices Type [Shipment Analysis by Value from 2018 to 2030]:

  • Aspiration Thrombectomy Devices
  • Percutaneous Mechanical Thrombectomy Devices

Clot Management Devices Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Diagnostic Centers
  • Hospitals
  • Others

Clot Management Devices Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Clot Management Devices Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies clot management devices companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the clot management devices companies profiled in this report include-

  • Medtronic
  • Boston Scientific Corporation
  • iVascular SLU
  • Teleflex
  • Edwards Lifesciences Corporation
  • LeMaitre Vascular
  • Vascular Solutions
  • Straub Medical
  • Cook Medical
  • DePuy Synthes

Clot Management Devices Market Insights

Lucintel forecasts that neurovascular embolectomy device is expected to witness highest growth over the forecast period because it helps in treating medical conditions like embolism, primarily occuring in brain bolld vessels.

Within this market, hospitals will remain the largest segment due to increasing adoption of specialized departments, advanced labs, and operating rooms in hospitals for cardiovascular treatments.

APAC is expected to witness highest growth over the forecast period due to increasing prevalence of cardiovascular diseases and improvement in the healthcare infrastructure in the region.

Features of the Global Clot Management Devices Market

Market Size Estimates: Clot management devices market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Clot management devices market size by product, percutaneous thrombectomy devices type, end use, and region. in terms of value ($B).

Regional Analysis: Clot management devices market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, percutaneous thrombectomy devices types, end uses, and region.s for the clot management devices market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the clot management devices market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the clot management devices market size?

Answer: The global clot management devices market is expected to reach an estimated $2.5 billion by 2030.

Q.2. What is the growth forecast for clot management devices market?

Answer: The global clot management devices market is expected to grow with a CAGR of 5.2% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the clot management devices market?

Answer: The major drivers for this market are rising prevalence of cardiovascular diseases and ageing population, increasing inclination towards minimally invasive surgeries and on-going advancements in technologies.

Q.4. What are the major segments for clot management devices market?

Answer: The future of the clot management devices market looks promising with opportunities in the diagnostic centers, and hospitals markets.future of the global clot management devices market looks promising with opportunities in the diagnostic center and hospital markets.

Q.5. Who are the key clot management devices market companies?

Answer: Some of the key clot management devices companies are as follows:

  • Medtronic
  • Boston Scientific Corporation
  • iVascular SLU
  • Teleflex
  • Edwards Lifesciences Corporation
  • LeMaitre Vascular
  • Vascular Solutions
  • Straub Medical
  • Cook Medical
  • DePuy Synthes

Q.6. Which clot management devices market segment will be the largest in future?

Answer: Lucintel forecasts that neurovascular embolectomy device is expected to witness highest growth over the forecast period because it helps in treating medical conditions like embolism, primarily occuring in brain bolld vessels.

Q.7. In clot management devices market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to increasing prevalence of cardiovascular diseases and improvement in the healthcare infrastructure in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the clot management devices market by product (neurovascular embolectomy devices, embolectomy balloon catheters, percutaneous thrombectomy devices,catheter-directed thrombolysis (CDT) devices, and inferior vena cava filters (IVCF)), percutaneous thrombectomy devices type (aspiration thrombectomy devices and percutaneous mechanical thrombectomy devices), end use (diagnostic centers, hospitals, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Clot Management Devices Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Clot Management Devices Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Clot Management Devices Market by Product
    • 3.3.1: Neurovascular Embolectomy Devices
    • 3.3.2: Embolectomy Balloon Catheters
    • 3.3.3: Percutaneous Thrombectomy Devices
    • 3.3.4: Catheter-Directed Thrombolysis (CDT) Devices
    • 3.3.5: Inferior Vena Cava Filters (IVCF)
  • 3.4: Global Clot Management Devices Market by Percutaneous Thrombectomy Devices Type
    • 3.4.1: Aspiration Thrombectomy Devices
    • 3.4.2: Percutaneous Mechanical Thrombectomy Devices
  • 3.5: Global Clot Management Devices Market by End Use
    • 3.5.1: Diagnostic Centers
    • 3.5.2: Hospitals
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Clot Management Devices Market by Region
  • 4.2: North American Clot Management Devices Market
    • 4.2.2: North American Clot Management Devices Market by End Use: Diagnostic Centers, Hospitals, and Others
  • 4.3: European Clot Management Devices Market
    • 4.3.1: European Clot Management Devices Market by Product: Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices,Catheter-Directed Thrombolysis (CDT) Devices, and Inferior Vena Cava Filters (IVCF)
    • 4.3.2: European Clot Management Devices Market by End Use: Diagnostic Centers, Hospitals, and Others
  • 4.4: APAC Clot Management Devices Market
    • 4.4.1: APAC Clot Management Devices Market by Product: Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices,Catheter-Directed Thrombolysis (CDT) Devices, and Inferior Vena Cava Filters (IVCF)
    • 4.4.2: APAC Clot Management Devices Market by End Use: Diagnostic Centers, Hospitals, and Others
  • 4.5: ROW Clot Management Devices Market
    • 4.5.1: ROW Clot Management Devices Market by Product: Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices,Catheter-Directed Thrombolysis (CDT) Devices, and Inferior Vena Cava Filters (IVCF)
    • 4.5.2: ROW Clot Management Devices Market by End Use: Diagnostic Centers, Hospitals, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Clot Management Devices Market by Product
    • 6.1.2: Growth Opportunities for the Global Clot Management Devices Market by Percutaneous Thrombectomy Devices Type
    • 6.1.3: Growth Opportunities for the Global Clot Management Devices Market by End Use
    • 6.1.4: Growth Opportunities for the Global Clot Management Devices Market by Region
  • 6.2: Emerging Trends in the Global Clot Management Devices Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Clot Management Devices Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Clot Management Devices Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Medtronic
  • 7.2: Boston Scientific Corporation
  • 7.3: iVascular SLU
  • 7.4: Teleflex
  • 7.5: Edwards Lifesciences Corporation
  • 7.6: LeMaitre Vascular
  • 7.7: Vascular Solutions
  • 7.8: Straub Medical
  • 7.9: Cook Medical
  • 7.10: DePuy Synthes